SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886163-19-000199
Filing Date
2019-11-08
Accepted
2019-11-08 16:05:45
Documents
60
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lgnd-20190930.htm   iXBRL 10-Q 2102984
2 EX-31.1 lgnd93019exhibit311.htm EX-31.1 20761
3 EX-31.2 lgnd93019exhibit312.htm EX-31.2 21091
4 EX-32.1 lgnd93019exhibit321.htm EX-32.1 15175
10 lgnd-20190930_g1.jpg GRAPHIC 11735
  Complete submission text file 0000886163-19-000199.txt   8620153

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lgnd-20190930.xsd EX-101.SCH 41182
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lgnd-20190930_cal.xml EX-101.CAL 109325
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lgnd-20190930_def.xml EX-101.DEF 252488
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lgnd-20190930_lab.xml EX-101.LAB 637558
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lgnd-20190930_pre.xml EX-101.PRE 401329
19 EXTRACTED XBRL INSTANCE DOCUMENT lgnd-20190930_htm.xml XML 1690800
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 191204072
SIC: 2834 Pharmaceutical Preparations